Department of Medical Microbiology, University Medical Center Utrecht, 3584, CX Utrecht, The Netherlands.
Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, 66506.
Protein Sci. 2018 Feb;27(2):509-522. doi: 10.1002/pro.3342. Epub 2017 Nov 21.
Neutrophils contain high levels of chymotrypsin-like serine proteases (NSPs) within their azurophilic granules that have a multitude of functions within the immune system. In response, the pathogen Staphylococcus aureus has evolved three potent inhibitors (Eap, EapH1, and EapH2) that protect the bacterium as well as several of its secreted virulence factors from the degradative action of NSPs. We previously showed that these so-called EAP domain proteins represent a novel class of NSP inhibitors characterized by a non-covalent inhibitory mechanism and a distinct target specificity profile. Based upon high levels of structural homology amongst the EAP proteins and the NSPs, as well as supporting biochemical data, we predicted that the inhibited complex would be similar for all EAP/NSP pairs. However, we present here evidence that EapH1 and EapH2 bind the canonical NSP, Neutrophil Elastase (NE), in distinct orientations. We discovered that alteration of EapH1 residues at the EapH1/NE interface caused a dramatic loss of affinity and inhibition of NE, while mutation of equivalent positions in EapH2 had no effect on NE binding or inhibition. Surprisingly, mutation of residues in an altogether different region of EapH2 severely impacted both the NE binding and inhibitory properties of EapH2. Even though EapH1 and EapH2 bind and inhibit NE and a second NSP, Cathepsin G, equally well, neither of these proteins interacts with the structurally related, but non-proteolytic granule protein, azurocidin. These studies expand our understanding of EAP/NSP interactions and suggest that members of this immune evasion protein family are capable of diverse target recognition modes.
中性粒细胞的嗜天青颗粒中含有高水平的糜蛋白酶样丝氨酸蛋白酶(NSPs),这些蛋白酶在免疫系统中具有多种功能。作为回应,病原体金黄色葡萄球菌进化出了三种强效抑制剂(Eap、EapH1 和 EapH2),这些抑制剂既能保护细菌,又能保护其几种分泌的毒力因子免受 NSPs 的降解作用。我们之前曾表明,这些所谓的 EAP 结构域蛋白代表了一类新型的 NSP 抑制剂,其特征为非共价抑制机制和独特的靶标特异性谱。基于 EAP 蛋白和 NSPs 之间高水平的结构同源性,以及支持的生化数据,我们预测所有 EAP/NSP 对的抑制复合物都将相似。然而,我们在此提出证据表明,EapH1 和 EapH2 以不同的取向结合经典的 NSP,中性粒细胞弹性蛋白酶(NE)。我们发现,EapH1 上与 EapH1/NE 界面相关的残基的改变导致与 NE 的亲和力和抑制作用显著丧失,而 EapH2 中等效位置的突变对 NE 结合或抑制没有影响。令人惊讶的是,EapH2 中完全不同区域的残基突变严重影响了 EapH2 的 NE 结合和抑制特性。尽管 EapH1 和 EapH2 同样能结合和抑制 NE 和第二种 NSP,组织蛋白酶 G,但这两种蛋白质都不会与结构相关但非蛋白水解的颗粒蛋白,天青杀素相互作用。这些研究扩展了我们对 EAP/NSP 相互作用的理解,并表明该免疫逃避蛋白家族的成员能够识别不同的靶标。